37 min listen
Pharmacy Benefits and Disease-Modifying Therapies
Pharmacy Benefits and Disease-Modifying Therapies
ratings:
Length:
20 minutes
Released:
Feb 14, 2022
Format:
Podcast episode
Description
Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the impact of Medicare Part D plan disease-modifying therapy restrictiveness upon adherence and outcomes among patients with multiple sclerosis. Read the full article in Neurology: Clinical Practice.
Released:
Feb 14, 2022
Format:
Podcast episode
Titles in the series (100)
September 4 2007 Issue: Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients. by Neurology® Podcast